chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 54 year old male with no drug allergies who on 26-AUG-2008 was vaccinated with PNEUMOVAX 23 (lot #659150/1384U).  The physician reported that on 27-AUG-2008 the patient developed a severe local and systemic reaction to vaccination with PNEUMOVAX 23.  The local reaction was erythema 3 inches in diameter that was warm, red and swollen.  The patient had had trouble raising his arm over his head, and had spent the last 3 days in bed.  The systemic reaction was described as a fever up to 102 degrees F, general malaise, headache and generalized muscle and joint pain described as arthralgia.  The patient had no known history of a previous vaccination with PNEUMOVAX 23.  At the time of the report the patient was recovering.  No further information was available to report.  A lot check has been requested.  The physician considered erythema 3 inches in diameter that was warm, red and swollen; trouble raising his arm over his head; spent the last 3 days in bed; fever up to 102 degrees F; general malaise; headache; and generalized muscle and joint pain to be disabling.  Additional information has been requested.
Injection site reaction. Burning sensation after injection, swelling of the injection site about 4 inches in diameter. Next day, I experienced pain at the injection site where the swelling is. On day 2 the swelling is very itchy. Seems to only happen with Moderna shots. No issues when I took Pfizer booster the last time.
More tired than normal; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (More tired than normal) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced FATIGUE (More tired than normal). At the time of the report, FATIGUE (More tired than normal) outcome was unknown.            Treatment medications were not reported by the reporter. No concomitant medications were provided by reporter.   Reporter did not allow further contact
Patient was administered the COVID 19 vaccination.  Approximately 2 minutes after  administration, he alerted pharmacy staff that he wasn't feeling well and stated he felt lightheaded.  I went out to the patient in the waiting area at which point he asked for a water.  I got him a water and the patient fell off the vaccination seat onto the floor (unsure if he hit his head).  Another pharmacy associate called 911 and myself and another customer in the store assisted the gentleman up to his seat.  Once seated after taking some sips of water, he began saying that he felt okay.  By this point, the ambulance and the patient's father had arrived.  Patient told EMTs that he felt okay, but they insisted that they take him outside to get his vitals before his father take him home.
SUDDEN ONSLAUGHT OF CANCER; This spontaneous report received from a consumer concerned a female of unspecified age and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose not reported, 1 total (dose series 1), for prophylactic vaccination (date unspecified). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient died 6 weeks after her injection from sudden onslaught of cancer. As per reporter they stated that "there's my stepdaughter who died 6 weeks after her injection from sudden onslaught of cancer" On an unspecified date, the patient died from sudden onslaught of cancer. It was unknown if autopsy were performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0:20211225989-COVID-19 VACCINE AD26.COV2.S-Sudden onslaught of cancer. This event(s) is considered not related. The event(s) shows an incompatible temporal relationship.; Reported Cause(s) of Death: SUDDEN ONSLAUGHT OF CANCER
pretty bad eye effusion on the left eye; mild pain in the arm of the injection ( left arm); Headache; This spontaneous case was reported by a consumer and describes the occurrence of EFFUSION (pretty bad eye effusion on the left eye), VACCINATION SITE PAIN (mild pain in the arm of the injection ( left arm)) and HEADACHE (Headache) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical history was reported.).   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced VACCINATION SITE PAIN (mild pain in the arm of the injection ( left arm)) and HEADACHE (Headache). On an unknown date, the patient experienced EFFUSION (pretty bad eye effusion on the left eye). At the time of the report, EFFUSION (pretty bad eye effusion on the left eye), VACCINATION SITE PAIN (mild pain in the arm of the injection ( left arm)) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported Took Tylenol for headache and vaccination site pain
PT. c/o "feeling like throat is swelling", "feels funny",  Benadryl 25mg. PO given per PA verbal order  no rash/hives noted @ this time,  VS stable, 166/78, 99% oxygen sat, 66 heart rate pt. speaking in full sentences
1st dose on 21-oct-2021 and second dose was given 2nd dose past the 6 month timeframe; reporter was not confirm about 1st dose/possible delayed 2nd dose; 1st dose given it in the back of the arm; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) (batch number F5TT2, expiry date unknown) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On 21st October 2021, the patient received the 1st dose of Shingrix. On 21st October 2021, not applicable after receiving Shingrix and Shingrix, the patient experienced vaccine administered at inappropriate site. On an unknown date, the patient experienced drug dose administration interval too long and circumstance or information capable of leading to medication error. On an unknown date, the outcome of the drug dose administration interval too long, vaccine administered at inappropriate site and circumstance or information capable of leading to medication error were unknown.   Additional Information: GSK Receipt Date: 6-May-2022 Reporter's comments: The reporter was administering Shingrix 2nd dose into the deltoid muscle of patient and the patient asked, why you gave it intramuscular, the last time it was given it in the back of the arm. The reporter could not confirm that the first dose was administered into the back of the arm (as it was administered at another facility), but the patient stated that it was (also patient did not stated that it was administered subcutaneously).  It was not verified with reporter when the 2nd dose was administered but possibly the patient received the 2nd dose past the 6 month timeframe. The reporter consented to follow up via postal. Lot number not identifying as a GSK (GlaxoSmithKline) vaccine when entered into the batch identifier and the reporter did not have an expiry date. Additional Supportive Information: The reporter was not sure about 1st dose administration site but as patient mentioned it was given back of arm, it led to vaccine administered to inappropriate site. Also, the 2nd dose was possibly given later than recommended timeframe, which was circumstance of information leading to medication error and if interval is incorrect, it would led to lengthening of vaccination schedule.
Pt had red raised welt 8 cm x 4 1/2 cm hot to the touch. (Sensitive) to left arm.
Dyspnea, wheezing, dull aches in thighs from his hip to his knee, along with weakness of hips.  Nonproductive cough, chest discomfort; hot and cold flashes started on 6/9/07; Oxygen sats 97% on 2 litres of oxygen; inspiratory wheezes, prolonged expiratory wheezes; no rash; Antibiotics used included Levaquin, Solumedrol, Relafen, Xoponex, Dexpax, Advair.  Symptoms started about 18 hours after vaccine given.  6/25/07 Received hospital med recs which reveal patient experienced dyspnea & wheezing, dull aches of thighs from hip to knee, hot/cold flashes, non productive cough & central chest discomfort beginning approx 18 hrs s/p vax.  Admitted 6/10-6/18/2007 when transferred to unknown higher level of care. Developed sacroiliac & lower back pain.  Continued to have DOE. T/C to reporter to request additional hospital info. V/M left for return call. LABS: WBC 10.9, peak at 27.9, lymphs low at 15, grans high at 91.  UA WNL.  ABG revealed pO2 60.  Normal EKG.  Mycoplasma pneumoniae IgG positive at 277, IgM negative.  Legionella, sputum & blood c/s were negative. FINAL DX: Reactive airway disease, arthralgias and probable reaction to anthrax vax. Per 60 day follow up: Continues to have SOB & arthralgia. Being followed by rheumatology. CHURG STRAUSS syndrome being ruled out.
About 4:00 pm Patient waves at RN. RN went to patient and she said feeling dizzy, nausea, hot. Ambulance came. Observed. No treatment.
Information has been received from a female consumer who on 14-APR-2010 was vaccinated with her first dose of GARDASIL (lot# not reported).  On 15-APR-2010 the consumer experienced a "rash on her face".  It was unknown if the patient sought medical attention.  At the time of the report, the outcome of the patient was unknown.  No further information is available.
TDAP given to patient on 8/21/2018 and another TDAP given on 10/02/2018, 11 days apart. No reaction noted on date of injection. Patients parent aware of error in vaccine schedule administration. Multiple attempts made to talk to parent but unable to follow up due to parent not accepting phone calls.
pt recv vax 10NOV95 & 25MAR97 pt devel numerous small to medium raised erythematous spots which lasted approx 8 days;pt eval by MD & dx w/probable atypical chickenpox;tx w/DPh & colloidal oatmeal (aveeno) baths;
I had continued pain in my left arm that wasn't before the vaccine. I had physical therapy got little better not as before.  In September 2021 got a cortisone shot and just finished a round of Physical Therapy.
3-4 days after 2nd shot of Pfizer covid vaccine patient developed a rash clinically consistent with a symmetric drug-related intertriginous & flexural exanthem. The rash was itchy and self-resolved over the course of the next week without intervention. No h/o such reaction after the 1st shot of the Pfizer vaccine. No h/o similar reaction with any other vaccines or meds.
After day 3:Heart pain Lung pain  Weak Tired Heart fluttered  1 week after : All within 1 day Severe fast onset headache , bulging eyes , pain behind eyes . Sensitive to any sound or light . Never felt anything like it in my life  Following  day  after headache  : eyeballs had blood in eyes . Took about a week before the blood turned to a yellow color and started fading . Same day felt pain like small piercing pain behind right calf . And behind upper thigh. Upper thought was piecing and dull. Both sensitive  when I tried to touch my skin . . Continue to have heart flutter since vaccine and at times trying to catch breath during flutter . Comes on when resting or active .
In days after vaccine we noticed swelling in her right wrist and she no longer used the wrist. She complained of pain. Was later diagnosed with Juvenile Arthritis.
Knee popping that was excessive, that was not normal for me. I'm hitting 30 and I was more overweight at the time than I am currently, could have to do with that. I had stopped my birth control 2/2021 by an Endo, I got a period 2 times that month, once right after and later that was scheduled. and they were actually pretty heavy, especially the first one. When I'm off birth control, it's erratic and heavy and painful. When I'm on birth control, they're 4 days, and they are heavy then light and When I'm off of birth control, it'll be 4-6 weeks and very heavy with 5-7+ days. The longer I go from not taking birth control, they're longer and more erratic. After the vaccine, they were lighter and shorter. They were further apart, which is normal. but lighter, which is not normal. Recovered from knee popping, but not the periods. Didn't do to the doctor for the periods, but noted it at visits.
pt recv vax 14DEC94 & arm remained sore;MAR95 shoulder was x-rayed & pt was prescribed ASA which did not help;5APR95 given unspecified shot in shoulder which provided instant relief;
pt recv vax 1NOV96 pt devel vomit & diarrhea w/o fever 48hr p/inj;this is 1 of 25 cases reported;
Information has been received from a nurse practitioner concerning an 11 year old patient who was vaccinated IM with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patient developed a very severe local reaction to the vaccine. Unspecified medical attention was sought. The patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Patient developed facial swelling and urticarial rash shortly after injections were administered which revolved with Benadryl.
Patient reports having >50 itchy pustule eruptions on the skin all over her body. (states that it looks like chicken pox) Patient was advised to contact her Dr. for examination.
-Unresponsive (blank stare); neurological - great difficulty walking (could barely move feet); Stroke-like symptoms < 24 hours of receiving the 2nd Moderna dose. -Taken to ER (PM - after-hours); Patient was admitted. -Testing battery included: MRI , both with and w/o contrast; CAT scan; blood work. -All testing results were within normal ranges. No evidence of stroke, heart attack, etc. -Discharged after 3 days. -Symptoms continue to happen intermittently. Some days patient displays a lack of cognition of her surroundings; impaired memory; cannot remember birthday, cannot sign her name, etc. Other days she displays more "normal" behavior.
Evening  of 3/5 I had chills and headache and then overnight I also developed body aches.  Started to feel better by afternoon of 3/6 but tired rest of day. Felt fine by late evening on 3/6. On about 3/8 I developed a rash on my inner elbow of right arm and still have that rash today
High fever,  throwing up;  severe body aches, diarrhea; not able to eat for 24 hours; extreme fatigue; very weak for 24 hours  and fatigue for 48 to 72 hours afterwards
Fever of 101.5 for about 18 hours. Shivering. Exhausted.
9 DAYS AFTER VACCINATION PATIENT GOT "COVID ARM" RED, PAIN, INFLAMMATION, ACHING ARM. OTHER SX INCLUDED HA/MIGRAINE, ACHING LOW BACK. TODAY WHEN SHE PRESENTED FOR SECOND SHOT SHE FELT ALMOST FULLY RECOVERED.
Warm; Hardness; Itchy; Swelling; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history reported by the reporter.  Concomitant products included SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE WARMTH (Warm), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.; Sender's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
headache; Nasal congestion; sinus pressure; fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP).  A 23-year-old male patient received bnt162b2 (BNT162B2), administration date 02Feb2021 (Lot number: EM9809) at the age of 22 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: HEADACHE (non-serious) with onset 16Aug2021, outcome "recovering", described as "headache"; NASAL CONGESTION (non-serious) with onset 16Aug2021, outcome "recovering", described as "Nasal congestion"; PARANASAL SINUS DISCOMFORT (non-serious) with onset 16Aug2021, outcome "recovering", described as "sinus pressure"; FATIGUE (non-serious) with onset 16Aug2021, outcome "recovering", described as "fatigue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, nasal congestion, paranasal sinus discomfort, fatigue.  Clinical course included "Nasal congestion, sinus pressure, fatigue, headache".  Additional Information: Patient did not have COVID infection prior vaccination. Patient was tested for COVID post vaccination. No other vaccine was administered in four weeks. No other medications were administered in two weeks.  No follow-up attempts are possible. No further information is expected.
Vomiting, shortness of breath, fast heartbeat, leg, hands and head tremors.
Pt had a seizure lasting around 45 minutes. taken to ER by ambulance. Given Tylenol, Ativan, Rocephin, and Vancomycin.
About 13 days after receiving the vaccine, I developed a red, slightly raised area on my arm in the area near the vaccination.  The area was not itchy , painful or swollen.  I did nothing to treat it and researched it online since I knew that this type of reaction could happen after the Covid-19 vaccine.  I did not seek medical care.
Back started itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Back started itching) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Neurontin. Past adverse reactions to the above products included Hallucination with Neurontin. Concurrent medical conditions included Anemic. Concomitant products included FOLIC ACID for Anemic.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PRURITUS (Back started itching). At the time of the report, PRURITUS (Back started itching) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medication was not provided.   This case was linked to MOD-2021-406143, MOD-2021-406209 (Patient Link).
Information has been received from a physician concerning three patients over the age of 65 years old who were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot # 658450/1380U). The physician reported that the patients had injection site reactions after the injection was administered. The physician had no specific information on two of the patients. He mentioned that one patient who had extreme redness extending into the axillary area which seemed to follow the lymphatic system. A follow up telephone call to the doctor's office was made to obtain more information about the patients. No more information was available at this time. The outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
A 34 yr old female pt who presents today with c/o local reaction to recent Tdap (Adacel) injection. Injection was given 2/1/06. Now with left arm injection site swelling, localized and generalized aches, generalized chills, low grade fever per patient. States the redness and swelling has increased from yesterday, taking tylenol/motrin ATC. No streaking noted down arm. No SOB, respiratory sx, GI c/o to report. No hx of adverse rxn in the past. Denies any URI sx at time of injection.  General Appearance: well appearing, in no acute distress, alert Skin: left deltoid area/arm with noted 5 X 5.5 cm diameter induration, errythematous, warm, and tender to touch. Marked with pen. Swollen to 5 mm. Lungs: Lungs clear to auscultation, No wheezing or rhonchi Heart: negative. RRR without murmur, gallop, or rubs.  No ectopy. Abdomen: Abdomen soft, non-tender. Bowel sounds normal. No masses, organomegaly  A/P E948.4 ADV EFF TETANUS VACCINE 782.1 NONSPECIF SKIN ERUPT NEC Note: Given presentation of symptoms, will treat, injection site reaction/mild cellulitis- warning signs to report. Area marked with pen, to report if area of induration increases or develops high fever. Patient verbalizes understanding. Plan: KEFLEX 250 MG CAP      Continue Motrin/Tylenol combo for symptomatic management
Patient received the flu HD in right arm and pneumo 23 in left arm. She reports feeling very under the weather the night the received the shots and in the arm that received the pneumo 23 she reports red blotches (measuring 1-2 inches in diameter). The left arm was very very painful and difficult to move due to the pain; it lasted 2 days. She said that she stayed in bed the day following the shots because she felt so badly. One red blotch was still on her arm today (today is Day 3), but she is up and feeling much better. I asked her to report the reaction to her doctor and I explained that I would report this reaction to VAERS.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Nausea-Severe, Systemic: Vomiting-Severe, Additional Details: pt recieved the vaccine and after 6-7 mins passed out on the floor... she was woken up after 10-15 seconds and was moved to an upright position,. she then started to vomit 2-3 times 911 was called and emt took to hospital
At first had chills and fever and cold all over the body in Lung and Chest area coughing and coughing up mucus and weight loss and now in upper body chest congestion, breathing problem.
Significant fatigue, muscle ache, headache, and periorbital edema following second vaccine dose.  No evidence of anaphylaxis.  Pt w/history of sig seasonal allergies that are particularly bad at the moment.  S/s developed 6-12 hours after the 2nd dose.  She rested and hydrated.  She took a single OTC Claritin.   Pt instructed to rest, use IBU 600mg q6h and continue Claritin.  Follow up outlined.
pt recv vax & 2wk later devel urticaria; No further details were provided;
received the below shots on 12/11/09 and developed Henoch-Schonleion purpura on 12/21/09
(L) upper arm cellulitis 16cm x 13cm area. Seen in office 1/12/12 at 8am.
pt recv vax & devel severe aches & fever for several days;hx included rheumatoid arthritis;pt eventually recovered & also recv addtl med for arthritic flares;this is one of 3 pts from this site who exp above rxn,p/lot# 4958106
Local reaction of large 1 1/2 x 3" red, warm & itchy spot - lasting 3 days.